Annual Newsletter 2017

Download a copy here. Newsletter_Autumn_2017.pdf

Latest

MIRO - A New Biomarker for Parkinson's?

Researchers at Stanford University in the US looking for new biomarkers of Parkinson's, recently identified a protein called MIRO that in initial data very accurately identifies people with the condition...
The Simvastatin Study Protocol

The Cure Parkinson's Trust (CPT) is co-funding the ongoing PD-STAT clinical trial evaluating the disease modifying potential of the cholesterol lowering drug simvastatin in our Linked Clinical Trials programme. The trial protocol has recently been published...
The Bydureon Phase lll Trial to Begin Recruiting

The next phase of the Exenatide-PD clinical trial will begin recruiting to determine, in a larger cohort, whether this diabetes treatment can slow down disease progression in Parkinson’s...
The Grouse & Grape Luncheon 2019

The ninth annual Grouse & Grape Luncheon was held on Tuesday 8 October at the historic Spencer House, and attracted 300 guests who raised over £35,000 for The Cure Parkinson’s Trust.

MIRO - A New Biomarker for Parkinson's?

Researchers at Stanford University in the US looking for new biomarkers of Parkinson's, recently identified a protein called MIRO that in initial data very accurately identifies people with the condition...
The Simvastatin Study Protocol

The Cure Parkinson's Trust (CPT) is co-funding the ongoing PD-STAT clinical trial evaluating the disease modifying potential of the cholesterol lowering drug simvastatin in our Linked Clinical Trials programme. The trial protocol has recently been published...
The Bydureon Phase lll Trial to Begin Recruiting

The next phase of the Exenatide-PD clinical trial will begin recruiting to determine, in a larger cohort, whether this diabetes treatment can slow down disease progression in Parkinson’s...
The Grouse & Grape Luncheon 2019

The ninth annual Grouse & Grape Luncheon was held on Tuesday 8 October at the historic Spencer House, and attracted 300 guests who raised over £35,000 for The Cure Parkinson’s Trust.
LRRK2 - Parkinson's, Leprosy, and Crohn’s

Researchers in Ottawa have announced a new discovery associated with the LRRK2 genetic form of Parkinson's...
'Voyager' Recruits Patients for Phase 2 Gene Therapy Delivery

Voyager Therapeutics announced it is recruiting participants for the company’s Phase 2 trial of gene therapy, VY-AADC02, for advanced Parkinson’s enrolling in US...
Martin Wishart's Atlantic Sail for CPT

To mark the 20th anniversary of running his Edinburgh restaurant, Scottish Michelin Star Chef Martin Wishart will be taking on the incredible challenge of sailing 3,500 miles across the Atlantic in a bid to raise awareness and funds for The Cure Parkinson’s Trust.
New Research on the Importance of Exercise

This week, researchers at the Radboud University Medical Centre in Nijmegen (the Netherlands) published the results of a clinical trial evaluating an 'at home' high intensity exercise regime in people with Parkinson's, and they found that it had a positive effect.
From Prostates to Parkinson's

Chinese researchers in collaboration with scientists from the University of Iowa have today published new research suggesting that a drug, called Terazosin - which is used to treat enlarged prostates and high blood pressure - could be a useful drug to re-purpose for Parkinson's.
Enterin Announce Clinical Trial Results

Recently announced results from a clinical trial provide interesting support for a major theory about Parkinson's, and hope for individuals suffering from one of the common non-motor issues, constipation.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more